Ignite Creation Date:
2024-05-05 @ 11:20 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00002255
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
1999-11-02
Brief Title:
An Open-Label Phase III Study of Recombinant Granulocyte Colony Stimulating Factor r-metHuG-CSF and Recombinant Erythropoietin rHuEPO Given Subcutaneously Along With Zidovudine AZT to Patients With the Acquired Immune Deficiency Syndrome AIDS or Severe AIDS-Related Complex ARC
Sponsor:
Organization:
NIH AIDS Clinical Trials Information Service